Incidence of nonmelanoma skin cancer in patients with vitiligo who applied ruxolitinib cream

J Eur Acad Dermatol Venereol. 2024 Oct 17. doi: 10.1111/jdv.20379. Online ahead of print.

Authors

Khaled Ezzedine¹, Albert Wolkerstorfer², Shaoceng Wei³, Abdelhak Amara Korba⁴, Deanna Kornacki³, David Rosmarin⁵

Affiliations

¹ Henri Mondor University Hospital and Université Paris-Est Créteil Val de Marne, Paris, France.
² Amsterdam University Medical Center, Amsterdam, Netherlands.
³ Incyte Corporation, Wilmington, Delaware, USA.
⁴ Incyte Biosciences International, Morges, Switzerland.
⁵ Indiana University School of Medicine, Indianapolis, Indiana, USA.

PMID: 39417427
DOI: 10.1111/jdv.20379

No abstract available

Publication types

Letter

Grants and funding

Incyte